相关实验视频

Updated: May 6, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

微针-阵列介导的GCV功能化的化物伊米达索酸框架-8纳米颗粒的通过皮肤传递用于KSHV治疗

Chengjing Liu¹, Xiuyuan Yin², Huiling Xu¹

¹Key Laboratory of Xinjiang Endemic and Ethnic Diseases, NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, School of Medicine, Shihezi University, Shihezi 832003, China.

International journal of molecular sciences

|December 17, 2024

概括

这项研究开发了一种新型的微针药物输送系统,使用酸伊米达框架-8 (ZIF-8) 装载甘西克洛维尔 (GCV). 这种系统在体内有效地抑制了卡波西的肉瘤相关疹病毒 (KSHV) 复制.

科学领域:

生物医学工程生物医学工程
材料科学材料科学材料科学
病毒学病毒学

背景情况:

卡波西肉瘤相关疹病毒 (KSHV) 是一种与恶性瘤有关的人类疹病毒,是艾滋病患者的主要死亡原因.
甘西克洛维尔 (GCV) 是KSHV的主要抗病毒药物,但其临床使用因特异性差和跨膜传递而受到限制,导致有毒副作用.
有效的药物递送系统对于提高GCV在细胞中的度和缓解KSHV进展至关重要.

研究的目的:

开发一种新的纳米传递系统,以改善针对KSHV的GCV传递.
用于制造装有GCV的微针阵列,这些GCV被封装在氧化物伊米达框架-8 (ZIF-8) 中.
评估微针阵列在抑制KSHV复制中的有效性.

主要方法:

酸伊米达框架-8 (ZIF-8),一种生物相容的多孔材料,合成并装载了甘西克洛维尔 (GCV).
一种聚甲基 (PDMS) 微针模具被用于制造含有GCV@ZIF-8纳米粒子 (MN/GCV@ZIF-8) 的微针阵列.
微针阵列的皮肤穿孔能力和体内抗KSHV活性进行了评估.

主要成果:

制造的MN/GCV@ZIF-8阵列证明了通过角层有效地穿透皮肤.
微针系统在体内显著抑制了KSHV的复制和分裂.
纳米输送系统成功将GCV输送到瘤部位,从而产生抗KSHV的效果.

结论:

开发的装有GCV@ZIF-8的微针阵列系统为向的KSHV治疗提供了一个有希望的策略.
这种方法克服了传统GCV的局限性,提高了药物的疗效,降低了毒性.
这项研究强调了基于ZIF-8的微针在治疗KSHV感染方面的潜力.

关键词:

卡波西的肉瘤相关的疹病毒.甘西克洛维尔 (ganciclovir) 是一种药物.微针微针是一种微针.纳米输送是如何实现的泽奥利特伊米达索酸框架-8-8

更多相关视频

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

相关概念视频

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Transdermal Drug Delivery Systems

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...